PMA device
Prometra Programmable Infusion Pump System
Infusyn Therapeutics, LLC · Pump, Infusion, Implanted, Programmable (LKK, Class III) · First FDA decision Feb 7, 2012, newest Jun 18, 2025Chronic pain
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
18
PMA pathway
Device trials
9
Naming "Prometra"
MAUDE reports
1,540
Brand "Prometra", since 2015
PubMed studies
9
Mentioning "Prometra"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Prometra Programmable Infusion Pump System
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 6 of 18 decisions filed under this name.
- PROMETRA PROGRAMMABLE INFUSION PUMP SYSTEMPMA supplement
P080012-S075 · Decided Jun 18, 2025 · 30 days after receipt · Normal 180 Day Track No User Fee
Device type: Pump, infusion, implanted, programmable (LKK) · Hospital Medicine & Nursing
- Prometra Programmable Infusion Pump SystemPMA supplement
P080012-S070 · Decided Jul 12, 2022 · 390 days after receipt · Normal 180 Day Track No User Fee
Device type: Pump, infusion, implanted, programmable (LKK) · Hospital Medicine & Nursing
- Prometra Programmable Infusion Pump SystemPMA supplement
P080012-S068 · Decided Jan 12, 2022 · 433 days after receipt · Panel Track
Device type: Pump, infusion, implanted, programmable (LKK) · Hospital Medicine & Nursing
3 more FDA decisions with a free account
Older decisions: P080012-S040, P080012-S031, P080012-S028, P080012-S023, P080012-S022, P080012-S021, P080012-S019, P080012-S012, P080012-S003, P080012-S002, P080012-S001, P080012
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Prometra", any status and sponsor, newest update first.
- Prometra Post-Approval StudyCompleted
Flowonix MedicalNot on our public-company list
NCT01854229 · 400 participants · Start Jun 20, 2013 · Primary completion Mar 15, 2023
Device: Prometra Programmable Intrathecal Infusion Pump · For: Chronic Pain; Cancer Pain; Intractable Pain and 1 more
Sites: La Jolla, California; Santa Barbara, California; Santa Rosa, California · 26 sites in all
Evolve Restorative CenterAcademic, hospital or other
NCT04096391 · 73 participants · Start Jun 5, 2019 · Primary completion Apr 11, 2022
Device: Flowonix Prometra® II Programmable Infusion System · For: Chronic Nonmalignant Pain; Pain, Intractable; Pain, Chronic
Sites: Santa Rosa, California
Bux, Anjum, MDAcademic, hospital or other
NCT04312685 · 120 participants (planned) · Start Jul 27, 2020 · Primary completion Apr 1, 2023
Device: Prometra II Programmable Pump system - Flowonix Medical · For: Pain; Pain, Chronic; Pain, Intractable and 1 more
Sites: Idaho Falls, Idaho; Overland Park, Kansas; Lexington, Kentucky · 8 sites in all
6 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Prometra", and for the whole product code for context.
This brand
1,540 reports: 300 malfunction, 1,170 injury, 66 death
Whole product code LKK
71,356 reports: 25,333 malfunction, 45,674 injury, 326 death
Newest reports for this brand
- Prometra IIOther
MW6002707 · Received Sep 23, 2026
Device type: Pump, Infusion, Implanted, Programmable (LKK)
Device problem as coded: Insufficient Device Problem Information
Patient problem as coded: Insufficient Information
- PROMETRA IIOther
MW6002474 · Received Sep 17, 2026
Device type: Pump, Infusion, Implanted, Programmable (LKK)
Device problem as coded: Pumping Stopped
Patient problem as coded: Diarrhea; Chills; Weight Changes
MW6000916 · Received Aug 12, 2026
Device type: Pump, Infusion, Implanted, Programmable (LKK)
Device problem as coded: Naturally Worn
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
2 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-1996-2021 · Started May 26, 2021
Reason given: Physician Order Form (PL-15400-00 Nov 2018) distributed is discontinued due to the text 'Refill the pump and program refill with the same medication removed prior to MRI' may be misinterpreted as 'reuse the same drug solution extracted from the pump prior to the MRI procedure', creating a possible risk of infection
Cause as FDA categorized it: Error in labeling · Device type: Pump, Infusion, Implanted, Programmable (LKK)
- Prometra Programmable 20mL Pump. Catalog No. 11827 The device is an implantable infusion pump. GTIN-14 00810335020082Open, Classified
Z-1120-2020 · Started Dec 24, 2019 · Posted by FDA Feb 10, 2020
Reason given: A pump alarm function anomaly in the pump firmware code may result in the pump not sending the expected error code notifications to the Programmer, or not emit an audible alarm tone in certain "out of tolerance" conditions associated with the pump's valve system.
Cause as FDA categorized it: Software change control · Device type: Pump, Infusion, Implanted, Programmable (LKK)
- Prometra II 20mL Pump. Catalog No. 13827 The device is an implantable infusion pump. GTIN-14 00810335020228Open, Classified
Z-1121-2020 · Started Dec 24, 2019 · Posted by FDA Feb 10, 2020
Reason given: A pump alarm function anomaly in the pump firmware code may result in the pump not sending the expected error code notifications to the Programmer, or not emit an audible alarm tone in certain "out of tolerance" conditions associated with the pump's valve system.
Cause as FDA categorized it: Software change control · Device type: Pump, Infusion, Implanted, Programmable (LKK)
10 more recall records with a free account
Published research
The most relevant PubMed records for "Prometra"[tiab]. The summary above synthesizes these.
- "Sonology" of programmable intrathecal pumps.
Saulino M, Gofeld M · Neuromodulation · 2014
- Long-term follow-up of a novel implantable programmable infusion pump.
Rauck R, Deer T, Rosen S, et al. · Neuromodulation · 2013Multicenter Study
- Antiplasmodial Compounds from Clerodendrum rotundifolium Oliv. and Oral Toxicity Assessment of the Leaf Extracts.
Adia MM, Ndukui JG, Akala HM, et al. · J Ethnopharmacol · 2026
- Antiplasmodial activity and phytochemical analysis of extracts from selected Ugandan medicinal plants.
Adia MM, Emami SN, Byamukama R, et al. · J Ethnopharmacol · 2016
- Medicinal plants used in malaria treatment by Prometra herbalists in Uganda.
Adia MM, Anywar G, Byamukama R, et al. · J Ethnopharmacol · 2014Research Support, Non-U.S. Gov't
- Real-World Safety Profile of Intrathecal Morphine Monotherapy vs Morphine-Bupivacaine Combination: A 10-Year MAUDE Database Analysis.
Mantilla-Santamaria AF, Vallejo S, Cedeno DL, et al. · Pain Physician · 2026Comparative Study
- Accuracy and efficacy of intrathecal administration of morphine sulfate for treatment of intractable pain using the Prometra(®) Programmable Pump.
Rauck R, Deer T, Rosen S, et al. · Neuromodulation · 2010
- Visualizing post genomics data-sets on customized pathway maps by ProMeTra-aeration-dependent gene expression and metabolism of Corynebacterium glutamicum as an example.
Neuweger H, Persicke M, Albaum SP, et al. · BMC Syst Biol · 2009Research Support, Non-U.S. Gov't
- Intrathecal administration of Infumorph® vs compounded morphine for treatment of intractable pain using the Prometra® programmable pump.
Rosen SM, Bromberg TA, Padda G, et al. · Pain Med · 2013Comparative Study, Controlled Clinical Trial
Other devices of this type
Also filed under product code LKK.
- SynchroMed Infusion System, Ascenda Intrathecal CathetersMedtronic, Inc. · PMA 2026
- Synchromed II Pump RemediationMedtronic, Inc. · PMA 2017
- Implantable System for RemodulinMedtronic, Inc. · PMA 2021
- Medstream Programmable Infusion SystemIntera Oncology · PMA 2014
- IsoMed Infusion SystemMedtronic, Inc. · PMA 2023
- INFUSAID Implantable Infusion Pump and AccessoriesIntera Oncology · PMA 2020
- Medtronic(R) Synchromed(Tm) Pump & Infusion SystemMedtronic, Inc. · PMA 2018
- 3000 Series Implantable Infusion Pump and the MedStream Programmable Infusion System and AccessoriesIntera Oncology · PMA 2020
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.